Intravitreal Bevacizumab in Central Retinal Vein Occlusion: 18-month Results of a Prospective Clinical Trial

Bevacizumab in Central Retinal Vein Occlusion: A Retrospective Analysis after 2 Years of Treatment

(2018) Andreas Stahl et al.   EUROPEAN JOURNAL OF OPHTHALMOLOGY

Natural History of Central Retinal Vein Occlusion: An Evidence-Based Systematic Review

(2010) Rachel L. McIntosh et al.   OPHTHALMOLOGY

Ranibizumab for Macular Edema following Central Retinal Vein Occlusion

(2010) David M. Brown et al.   OPHTHALMOLOGY

COMPARISON OF TWO DOSES OF INTRAVITREAL BEVACIZUMAB AS PRIMARY TREATMENT FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION

(2010) Lihteh Wu et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Visual improvement in central retinal vein occlusion (CRVO) following intravitreal injections of bevacizumab (Avastin®)

(2009) Peep V. Algvere et al.   ACTA OPHTHALMOLOGICA

Different properties of VEGF-antagonists: Bevacizumab but not Ranibizumab accumulates in RPE cells

(2009) Alexa Karina Klettner et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Intravitreal ranibizumab (Lucentis) for treatment of central retinal vein occlusion: a prospective study

(2009) Alexander Rouvas et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Monitoring Ocular Drug Therapy by Analysis of Aqueous Samples

(2009) Peter A. Campochiaro et al.   OPHTHALMOLOGY

Effects of Intraocular Ranibizumab and Bevacizumab in Transgenic Mice Expressing Human Vascular Endothelial Growth Factor

(2009) Katsuaki Miki et al.   OPHTHALMOLOGY

Early intravitreal bevacizumab for non-ischaemic central retinal vein occlusion

(2008) Florian Rensch et al.   ACTA OPHTHALMOLOGICA

Prospective Study of Intravitreal Ranibizumab as a Treatment for Decreased Visual Acuity Secondary to Central Retinal Vein Occlusion

(2008) Richard F. Spaide et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Intravitreal bevacizumab (Avastin(R)) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial

(2008) F Prager et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin)

(2008) M Georgopoulos et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Immunohistochemical localisation of intravitreally injected bevacizumab at the posterior pole of the primate eye: implication for the treatment of retinal vein occlusion

(2008) S Julien et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Ranibizumab for the Treatment of Macular Edema Associated with Perfused Central Retinal Vein Occlusions

(2008) Dante J. Pieramici et al.   OPHTHALMOLOGY